The potential of PBPK modeling in answering key questions around these drugs.
Hannah Jones, PhD
Advertisement
Senior Vice President, PBPK Consultancy Services, Certara
Articles by Hannah Jones, PhD
Advertisement
Latest Updated Articles
Accelerating the Progress of Kinase Inhibitors in OncologyPublished: May 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When AI Learns to Speak Every Language: An eCOA Migration Study
2
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
3
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
4
FDA Outlines New Superiority Standard for Future CAR-T Approvals
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
